Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$331M |
| 2 |
Chevron
CVX
|
+$266M |
| 3 |
Chipotle Mexican Grill
CMG
|
+$259M |
| 4 |
JPMorgan Chase
JPM
|
+$232M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$223M |
Top Sells
| 1 |
Apple
AAPL
|
+$707M |
| 2 |
Johnson & Johnson
JNJ
|
+$411M |
| 3 |
Amazon
AMZN
|
+$312M |
| 4 |
Walmart
WMT
|
+$285M |
| 5 |
Intuitive Surgical
ISRG
|
+$282M |
Sector Composition
| 1 | Healthcare | 17.74% |
| 2 | Technology | 14.99% |
| 3 | Financials | 10.9% |
| 4 | Consumer Discretionary | 8.96% |
| 5 | Real Estate | 8.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2851
TJX Companies
TJX
$156B
| $493K | ﹤0.01% |
+8,800
| New | +$493K |
|
|
GHL
2852
DELISTED
Greenhill & Co., Inc.
GHL
| $490K | ﹤0.01% |
+18,600
| New | +$490K |
|
|
SBOW
2853
DELISTED
SilverBow Resources, Inc.
SBOW
| $488K | ﹤0.01% |
18,300
+6,900
| +61% | +$184K |
|
|
AAMI
2854
Acadian Asset Management Inc.
AAMI
$1.67B
| $487K | ﹤0.01% |
39,300
-591,900
| -94% | -$7.33M |
|
2855
Cardiff Oncology
CRDF
$136M
| $486K | ﹤0.01% |
99,434
+65,467
| +193% | +$320K |
|
|
EFC
2856
Ellington Financial
EFC
$1.36B
| $483K | ﹤0.01% |
30,160
-14,239
| -32% | -$228K |
|
|
IHC
2857
DELISTED
Independence Holding Company
IHC
| $481K | ﹤0.01% |
13,410
-13,390
| -50% | -$480K |
|
2858
Vanguard High Dividend Yield ETF
VYM
$64.7B
| $479K | ﹤0.01% |
5,500
-2,500
| -31% | -$218K |
|
2859
FlexShares Quality Dividend Index Fund
QDF
$1.95B
| $478K | ﹤0.01% |
10,100
+4,400
| +77% | +$208K |
|
|
NVIV
2860
DELISTED
InVivo Therapeutics Holdings Corp
NVIV
| $478K | ﹤0.01% |
316
+150
| +90% | +$227K |
|
2861
Cerus
CERS
$226M
| $477K | ﹤0.01% |
+66,100
| New | +$477K |
|
|
APTO
2862
DELISTED
Aptose Biosciences, Inc.
APTO
| $477K | ﹤0.01% |
408
+375
| +1,136% | +$438K |
|
2863
Merus
MRUS
$5.08B
| $474K | ﹤0.01% |
24,000
-24,200
| -50% | -$478K |
|
2864
Victory Capital Holdings
VCTR
$4.58B
| $474K | ﹤0.01% |
+49,700
| New | +$474K |
|
|
ENFY
2865
Enlightify Inc.
ENFY
$16.4M
| $474K | ﹤0.01% |
45,418
+14,810
| +48% | +$155K |
|
2866
CB Financial Services
CBFV
$166M
| $472K | ﹤0.01% |
15,309
+7,576
| +98% | +$234K |
|
2867
Citizens Community Bancorp
CZWI
$162M
| $468K | ﹤0.01% |
33,413
-2,887
| -8% | -$40.4K |
|
2868
Moog Class B
MOG.B
$6.34B
| $466K | ﹤0.01% |
5,600
| – | – |
|
2869
WisdomTree
WT
$2.02B
| $466K | ﹤0.01% |
+54,900
| New | +$466K |
|
|
RDGT
2870
Ridgetech, Inc. Ordinary Shares
RDGT
$8.02M
| $466K | ﹤0.01% |
1,207
+542
| +82% | +$209K |
|
|
RELV
2871
DELISTED
Reliv International Inc
RELV
| $466K | ﹤0.01% |
92,280
+3,600
| +4% | +$18.2K |
|
|
TI.A
2872
DELISTED
Telecom Italia 10 Svg
TI.A
| $462K | ﹤0.01% |
85,635
+65,435
| +324% | +$353K |
|
2873
Arbutus Biopharma
ABUS
$886M
| $461K | ﹤0.01% |
48,766
-201,886
| -81% | -$1.91M |
|
2874
Tenax Therapeutics
TENX
$27.9M
| $461K | ﹤0.01% |
55
+3
| +6% | +$25.1K |
|
|
CEMI
2875
DELISTED
Chembio diagnostics, Inc.
CEMI
| $460K | ﹤0.01% |
43,800
+22,100
| +102% | +$232K |
|